The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2025

Filed:

Jul. 15, 2022
Applicant:

Milestone Pharmaceuticals Inc., Saint-Laurent, CA;

Inventors:

Francis Plat, Saint-Laurent, CA;

Douglas Wight, Saint-Laurent, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/277 (2006.01); A61K 31/7048 (2006.01); A61K 31/7076 (2006.01); A61K 45/06 (2006.01); A61K 47/18 (2017.01); A61P 9/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/277 (2013.01); A61K 31/7048 (2013.01); A61K 31/7076 (2013.01); A61K 45/06 (2013.01); A61K 47/183 (2013.01); A61P 9/06 (2018.01);
Abstract

The present invention is related to methods of treating cardiac arrhythmia, angina, or a migraine in a patient in need thereof, with a therapeutically effective amount of a compound having a structure according to the formula: the method comprising nasally administering to the patient (i) a first dose, and (ii) a second dose of an aqueous composition comprising a pharmaceutically acceptable acetate or methanesulfonate salt of compound I, or a racemate or enantiomer thereof, wherein the acetate or methanesulfonate salt of compound I, or the racemate or enantiomer thereof, is dissolved in the aqueous composition at a concentration of 350 mg/mL±50 mg/mL, and wherein the second dose of the compound is administered between 5 minutes and 25 minutes after the first dose.


Find Patent Forward Citations

Loading…